Literature DB >> 21697460

Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Steven C Katz1, Kristin Ryan, Naseem Ahmed, George Plitas, Umer I Chaudhry, T Peter Kingham, Seema Naheed, Cang Nguyen, Ponnandai Somasundar, N Joseph Espat, Richard P Junghans, Ronald P Dematteo.   

Abstract

Although obstructive jaundice has been associated with a predisposition toward infections, the effects of bile duct ligation (BDL) on bulk intrahepatic T cells have not been clearly defined. The aim of this study was to determine the consequences of BDL on liver T cell phenotype and function. After BDL in mice, we found that bulk liver T cells were less responsive to allogeneic or syngeneic Ag-loaded dendritic cells. Spleen T cell function was not affected, and the viability of liver T cells was preserved. BDL expanded the number of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg), which were anergic to direct CD3 stimulation and mediated T cell suppression in vitro. Adoptively transferred CD4(+)CD25(-) T cells were converted into Treg within the liver after BDL. In vivo depletion of Treg after BDL restored bulk liver T cell function but exacerbated the degrees of inflammatory cytokine production, cholestasis, and hepatic fibrosis. Thus, BDL expands liver Treg, which reduce the function of bulk intrahepatic T cells yet limit liver injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697460      PMCID: PMC3372324          DOI: 10.4049/jimmunol.1004077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Biliary obstruction selectively expands and activates liver myeloid dendritic cells.

Authors:  Joshua I Bleier; Steven C Katz; Umer I Chaudhry; Venu G Pillarisetty; T Peter Kingham; Alaap B Shah; Jesse R Raab; Ronald P DeMatteo
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

2.  IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.

Authors:  Annette Erhardt; Markus Biburger; Thomas Papadopoulos; Gisa Tiegs
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.

Authors:  Lequn Li; Wayne R Godfrey; Stephen B Porter; Ying Ge; Carle H June; Bruce R Blazar; Vassiliki A Boussiotis
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

4.  Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors.

Authors:  Steven C Katz; Venu G Pillarisetty; Joshua I Bleier; T Peter Kingham; Umer I Chaudhry; Alaap B Shah; Ronald P DeMatteo
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

5.  Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation.

Authors:  Chisato Saeki; Masanori Nakano; Hiroki Takahashi; Saburo Saito; Sadamu Homma; Hisao Tajiri; Mikio Zeniya
Journal:  Clin Immunol       Date:  2010-01-15       Impact factor: 3.969

6.  CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice.

Authors:  Hua-Xing Wei; Ya-Hui Chuang; Bofeng Li; Haiming Wei; Rui Sun; Yuki Moritoki; M Eric Gershwin; Zhe-Xiong Lian; Zhigang Tian
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage.

Authors:  Philip Wintermeyer; Chao-Wen Cheng; Stephan Gehring; Beth L Hoffman; Martin Holub; Laurent Brossay; Stephen H Gregory
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

8.  FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

Authors:  Noritoshi Kobayashi; Nobuyoshi Hiraoka; Wataru Yamagami; Hidenori Ojima; Yae Kanai; Tomoo Kosuge; Atsushi Nakajima; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

9.  Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

Authors:  Fan He; Zhishui Chen; Shengyuan Xu; Ming Cai; Min Wu; Hongzhou Li; Xiaoping Chen
Journal:  Surgery       Date:  2009-04-19       Impact factor: 3.982

10.  In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.

Authors:  Yulius Y Setiady; Jennifer A Coccia; Peter U Park
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

View more
  31 in total

1.  Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice.

Authors:  Kazutaka Tanabe; Kojiro Taura; Yukinori Koyama; Gen Yamamoto; Takahiro Nishio; Yukihiro Okuda; Kojiro Nakamura; Kan Toriguchi; Kenji Takemoto; Kenya Yamanaka; Keiko Iwaisako; Satoru Seo; Masataka Asagiri; Etsuro Hatano; Shinji Uemoto
Journal:  J Gastroenterol       Date:  2015-02-28       Impact factor: 7.527

2.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?

Authors:  Yuhua Xue; George Michalopoulos
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

4.  HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases.

Authors:  Steven C Katz; John Hardaway; Ethan Prince; Prajna Guha; Marissa Cunetta; Ashley Moody; Li Juan Wang; Vincent Armenio; N Joseph Espat; Richard P Junghans
Journal:  Cancer Gene Ther       Date:  2019-06-03       Impact factor: 5.987

Review 5.  The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Food Chem Toxicol       Date:  2020-07-05       Impact factor: 6.023

6.  Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Authors:  Steven C Katz; Rachel A Burga; Elise McCormack; Li Juan Wang; Wesley Mooring; Gary R Point; Pranay D Khare; Mitchell Thorn; Qiangzhong Ma; Brian F Stainken; Earle O Assanah; Robin Davies; N Joseph Espat; Richard P Junghans
Journal:  Clin Cancer Res       Date:  2015-04-07       Impact factor: 12.531

7.  Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver.

Authors:  Junaid Ibrahim; Andrew H Nguyen; Adeel Rehman; Atsuo Ochi; Mohsin Jamal; Christopher S Graffeo; Justin R Henning; Constantinos P Zambirinis; Nina C Fallon; Rocky Barilla; Sana Badar; Aaron Mitchell; Raghavendra S Rao; Devrim Acehan; Alan B Frey; George Miller
Journal:  Gastroenterology       Date:  2012-06-12       Impact factor: 22.682

8.  Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Authors:  Justin R Henning; Christopher S Graffeo; Adeel Rehman; Nina C Fallon; Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Mohsin Jamal; Michael Deutsch; Stephanie Greco; Melvin Ego-Osuala; Usama Bin-Saeed; Raghavendra S Rao; Sana Badar; Juan P Quesada; Devrim Acehan; George Miller
Journal:  Hepatology       Date:  2013-06-24       Impact factor: 17.425

Review 9.  Regulatory T cells in nonlymphoid tissues.

Authors:  Dalia Burzyn; Christophe Benoist; Diane Mathis
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

10.  Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.

Authors:  Steven M Strasberg; Feng Gao; Dominic Sanford; David C Linehan; William G Hawkins; Ryan Fields; Danielle H Carpenter; Elizabeth M Brunt; Carolyn Phillips
Journal:  HPB (Oxford)       Date:  2013-04-22       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.